Top

Journal of Experimental & Clinical Cancer Research

Published in:

Open Access 01-12-2021 | Melanoma | Correction

Correction to: Combination therapy of PKCζ and COX-2 inhibitors synergistically suppress melanoma metastasis

Authors: Ping Zhou, Jiaqi Qin, Yuan Li, Guoxia Li, Yinsong Wang, Ning Zhang, Peng Chen, Chunyu Li

Published in: Journal of Experimental & Clinical Cancer Research | Issue 1/2021

Excerpt

Correction to: J Exp Clin Cancer Res 36, 115 (2017) …

Zhou P, Qin J, Li Y, et al. Combination therapy of PKCζ and COX-2 inhibitors synergistically suppress melanoma metastasis. J Exp Clin Cancer Res. 2017;36:115. https://doi.org/10.1186/s13046-017-0585-2.CrossRefPubMedPubMedCentral

Title: Correction to: Combination therapy of PKCζ and COX-2 inhibitors synergistically suppress melanoma metastasis
Authors: Ping Zhou
Jiaqi Qin
Yuan Li
Guoxia Li
Yinsong Wang
Ning Zhang
Peng Chen
Chunyu Li
Publication date: 01-12-2021
Publisher: BioMed Central
Keywords: Melanoma
Melanoma
Celecoxib
Published in: Journal of Experimental & Clinical Cancer Research / Issue 1/2021
Electronic ISSN: 1756-9966
DOI: https://doi.org/10.1186/s13046-021-01885-y

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2021

Retraction Note: TLE3 represses colorectal cancer proliferation by inhibiting MAPK and AKT signaling pathways

LINC00680 enhances hepatocellular carcinoma stemness behavior and chemoresistance by sponging miR-568 to upregulate AKT3

Hsa_circ_0005273 facilitates breast cancer tumorigenesis by regulating YAP1-hippo signaling pathway

Circulating extracellular vesicles from individuals at high-risk of lung cancer induce pro-tumorigenic conversion of stromal cells through transfer of miR-126 and miR-320

Thrombospondin 4/integrin α2/HSF1 axis promotes proliferation and cancer stem-like traits of gallbladder cancer by enhancing reciprocal crosstalk between cancer-associated fibroblasts and tumor cells

TP53 drives abscopal effect by secretion of senescence-associated molecular signals in non-small cell lung cancer

Keynote webinar | Spotlight on antibody–drug conjugates in cancer